Stay updated on Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Updated the page revision from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:24:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now shows revision v3.4.2, replacing the previous v3.4.1. This is a minor metadata update that does not affect content, functionality, or user interactions.
    Difference
    0.1%
    Check dated 2026-02-12T01:40:03.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A minor revision label was updated from v3.4.0 to v3.4.1; no substantive study details or content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:30:13.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI and copy updates include a glossary toggle, new labeling for 'Last Update Submitted that Met QC Criteria', and a Revision: v3.4.0, along with related FEAR Act data wording adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T19:25:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 from the page. This is an administrative update to the version history and does not affect trial data, eligibility criteria, or study details.
    Difference
    0.1%
    Check dated 2026-01-14T03:53:37.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new Locations section appears with Connecticut listed, replacing the older Connecticut Locations header; the HHS Vulnerability Disclosure footer link and the older revision label were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:44:21.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page.